{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:52:30Z","timestamp":1761947550776,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.medmal.2009.02.032","type":"journal-article","created":{"date-parts":[[2009,4,25]],"date-time":"2009-04-25T05:41:08Z","timestamp":1240638068000},"page":"513-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Le traitement des m\u00e9ningites bact\u00e9riennes communautaires, apr\u00e8s identification microbiologique"],"prefix":"10.1016","volume":"39","author":[{"given":"J.-P.","family":"Stahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2009.02.032_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(07)70050-6","article-title":"Emergency diagnosis and treatment of bacterial meningitis in adult","volume":"7","author":"Fitsch","year":"2007","journal-title":"Lancet Infect"},{"key":"10.1016\/j.medmal.2009.02.032_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jac\/49.4.661","article-title":"Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands","volume":"49","author":"van de Beek","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.032_bib4","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0929-693X(02)00078-7","article-title":"M\u00e9ningite \u00e0 pneumocoque et r\u00e9sistance bact\u00e9rienne","volume":"9","author":"Floret","year":"2002","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.medmal.2009.02.032_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMra052116","article-title":"Community acquired bacterial meningitis in adults","volume":"354","author":"van de Beek","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2009.02.032_bib6","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1128\/AAC.47.8.2487-2491.2003","article-title":"Cefotaxim acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro","volume":"47","author":"K\u00fchn","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jac\/dkh082","article-title":"Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistances in penicillin-resistant pneumococci","volume":"53","author":"Flatz","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijantimicag.2005.06.010","article-title":"Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin and cephalosporin resistant pneumococal meningitis in an experimental rabbit model","volume":"26","author":"Suntur","year":"2005","journal-title":"Int J Antimicrob Ag"},{"key":"10.1016\/j.medmal.2009.02.032_bib9","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/AAC.48.10.3928-3933.2004","article-title":"Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis","volume":"48","author":"Cottagnoud","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib10","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1128\/AAC.01000-06","article-title":"Daptomycin produces an enhance bactericidal activity, compared to ceftriaxone, measured by (H3) choline release in cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain, without lysing its cell wall","volume":"51","author":"Stucki","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2003.07.015","article-title":"Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis","volume":"23","author":"Lee","year":"2004","journal-title":"Int J Antimicrob Ag"},{"key":"10.1016\/j.medmal.2009.02.032_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/46.6.981","article-title":"Linezolid in penicillin-sensistive and resistant pneumococci in the rabbit meningitis model","volume":"46","author":"Cottagnoud","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib13","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/AAC.47.6.1943-1947.2003","article-title":"Activities of ertapenem, a new long acting carbapenem, against penicillin-sensitive and -resistant pneumococci, in experimental meningitis","volume":"47","author":"Cottagnoud","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib14","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s100960050421","article-title":"Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain","volume":"18","author":"Gerber","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.032_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jac\/dkl047","article-title":"Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae","volume":"57","author":"Ribes","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jac\/dkh496","article-title":"Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis","volume":"55","author":"Fernandez","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1086\/313606","article-title":"Clinical outcome of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance","volume":"30","author":"Fiore","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.032_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1440-1754.2006.00824.x","article-title":"Rapid sterilisation of cerebrospinal fluid in meningococcal meningitis: implications for treatment duration","volume":"42","author":"Croswell","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.medmal.2009.02.032_bib19","doi-asserted-by":"crossref","unstructured":"R. Ellis-Pegler, L. Galler, S. Roberts, M. Thomas, A. Woodhouse. Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults. Clin Infect Dis 2003;37:658\u201362.","DOI":"10.1086\/377203"},{"key":"10.1016\/j.medmal.2009.02.032_bib20","unstructured":"R. G\u00fcerri, G. Vallecillo, F. S\u00e1nchez, E. Lerma, E. Sol\u00e9, J. Villar, et al. Is vancomycin necessary in empirical treatment of community-acquired meningitis? ECCMID 2008 (Barcelona); Abstract P721."},{"key":"10.1016\/j.medmal.2009.02.032_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/49.3.507","article-title":"Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis","volume":"49","author":"Martinez-Lacasa","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib22","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/314760","article-title":"Rifampicin reduces early mortality in experimental Streptococcus pneumoniae meningitis","volume":"179","author":"Nau","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.032_bib23","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1086\/315518","article-title":"Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis","volume":"181","author":"B\u00f6tcher","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.032_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01641429","article-title":"Influence of mannitol on the penetration of teicoplanin into infected CSF of experimental staphylococcus aureus meningitis of rabbits","volume":"18","author":"Manquat","year":"1990","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2009.02.032_bib25","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1128\/AAC.43.7.1651","article-title":"Comparative efficacies of antibiotics in a rat model of meningoencephalitis due to Listeria monocytogenes","volume":"43","author":"Michelet","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.032_bib26","first-page":"1385","article-title":"Neuromeningeal listeriosis in adults. Clinical aspects and contribution of cotrimoxazole in monotherapy","volume":"22","author":"Pin\u00e8de","year":"1993","journal-title":"Presse Med"},{"key":"10.1016\/j.medmal.2009.02.032_bib27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijantimicag.2005.08.005","article-title":"Cefotaxime and cefriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children","volume":"26","author":"Golwater","year":"2005","journal-title":"Int J Antimicrobial Agents"},{"key":"10.1016\/j.medmal.2009.02.032_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0140-6736(05)66792-X","article-title":"Ceftriaxone as effective as long-acting chloramphenicol in short course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study","volume":"366","author":"Nathan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2009.02.032_bib29","doi-asserted-by":"crossref","first-page":"254S","DOI":"10.1007\/BF01661286","article-title":"Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis","volume":"14","author":"Stahl","year":"1986","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2009.02.032_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11908-003-0011-0","article-title":"Fluoroquinolones in the treatment of meningitis","volume":"5","author":"Cottagnoud","year":"2003","journal-title":"Curr Infect Dis Rep"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X09000936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X09000936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:09:25Z","timestamp":1759972165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X09000936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":30,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0399077X09000936"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2009.02.032","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Le traitement des m\u00e9ningites bact\u00e9riennes communautaires, apr\u00e8s identification microbiologique","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2009.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}